Tarsus Pharmaceuticals, Inc.

TARS

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001819790

SEC filings (opens in a new tab)

In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Tarsus Pharmaceuticals, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of TARS: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	253	2	256	+5
Shares	45.1M	2.24M	47.3M	+4.42M (+10.3%)
Value	$3.17B	$157.3M	$2.98B	−$30.9M (−1.0%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (39)

Institutions that held Tarsus Pharmaceuticals, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to TARS in Q2 2026
Institution	Shares	Value	% of portfolio
Jupiter Topco LLC	2,808,796	$176.8M	0.07%
Massachusetts Financial Services Co	427,008	$26.9M	0.01%
Wasatch Advisors Inc	368,568	$23.2M	0.15%
Mackenzie Financial Corp	191,428	$12.0M	0.01%
Parkman Healthcare Partners LLC	150,000	$9.44M	0.97%
Schonfeld Strategic Advisors LLC	99,845	$6.28M	0.03%
Freestone Grove Partners LP	68,389	$4.30M	0.03%
Eversept Partners, LP	55,710	$3.51M	0.19%
Jacobs Levy Equity Management, Inc	53,636	$3.38M	0.01%
Atika Capital Management LLC	40,000	$2.52M	0.25%
OrbiMed Advisors LLC	35,581	$2.24M	0.04%
Entropy Technologies, LP	24,583	$1.55M	0.06%
Blair William & Co	22,053	$1.39M	0.00%
Norges Bank	16,672	$1.05M	0.00%
Jain Global LLC	15,219	$957.9K	0.01%
Wesbanco Bank Inc	14,000	$881.2K	0.02%
Tudor Investment Corp Et Al	9,541	$600.5K	0.00%
Brevan Howard Capital Management LP	7,993	$503.1K	0.01%
Magnetar Financial LLC	7,121	$448.2K	0.00%
Yorktown Management & Research Co Inc	4,950	$311.6K	0.19%
Quadrature Capital Ltd	4,880	$307.1K	0.00%
Mitsubishi UFJ Trust & Banking Corp	4,018	$252.9K	0.00%
MML Investors Services, LLC	3,808	$239.7K	0.00%
DRW Securities, LLC	3,712	$233.6K	0.01%
Blueshift Asset Management, LLC	3,697	$232.7K	0.05%
Rafferty Asset Management, LLC	3,242	$204.1K	0.00%
Nykredit A/S	1,679	$105.7K	0.00%
State of Wyoming	1,643	$103.4K	0.01%
Clear Street Markets LLC	634	$39.9K	0.01%
Aster Capital Management (DIFC) Ltd	120	$7.55K	0.00%
SRS Capital Advisors, Inc.	55	$3.46K	0.00%
Global Retirement Partners, LLC	47	$2.96K	0.00%
Ameritas Advisory Services, LLC	47	$2.96K	0.00%
Ares Financial Consulting, LLC	13	$818	0.00%
Clearstead Advisors, LLC	6	$378	0.00%
SWAN Capital LLC	5	$315	0.00%
Quarry LP	4	$252	0.00%
Keating Financial Advisory Services, Inc.	2	$126	0.00%
Silver Grove Financial Group, Inc.	1	$63	0.00%

Sold out (34)

Institutions that held Tarsus Pharmaceuticals, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of TARS in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Braidwell LP	265,715	$18.6M
Point72 Asset Management, L.P.	226,251	$15.9M
Integral Health Asset Management, LLC	200,000	$14.0M
M&G Plc	166,364	$11.6M
Ally Bridge Group (NY) LLC	80,859	$5.67M
Jump Financial, LLC	47,600	$3.34M
Calamos Advisors LLC	43,832	$3.07M
GordonMD Global Investments LP	42,680	$2.99M
Lisanti Capital Growth, LLC	41,815	$2.93M
Nomura Holdings Inc	34,685	$2.43M
Public Sector Pension Investment Board	32,000	$2.24M
Algert Global LLC	31,760	$2.23M
Capricorn Fund Managers Ltd	26,000	$1.82M
Diadema Partners LP	25,942	$1.82M
Man Group plc	23,252	$1.63M
Caxton Associates LLP	15,163	$1.06M
Zacks Investment Management	14,879	$1.04M
Legato Capital Management LLC	9,465	$664.0K
Persistent Asset Partners Ltd	6,556	$459.9K
Verdad Advisers, LP	6,328	$443.9K
Allianz Asset Management GmbH	4,600	$322.7K
Headlands Technologies LLC	4,322	$303.2K
Guggenheim Capital LLC	3,688	$258.7K
Lighthouse Investment Partners, LLC	3,287	$230.6K
M&T Bank Corp	3,035	$213.3K
Antipodes Partners Ltd	555	$38.9K
MAI Capital Management	299	$21.0K
Advisory Services Network, LLC	190	$13.3K
LRI Investments, LLC	41	$2.88K
Larson Financial Group LLC	36	$2.52K
Bare Financial Services, Inc	13	$912
Cullen/Frost Bankers, Inc.	6	$421
Quadrant Capital Group LLC	6	$421
Twin Peaks Wealth Advisors, LLC	1	$70

Not filed for Q2 2026 yet (2)

Institutions that held Tarsus Pharmaceuticals, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TARS in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Janus Henderson Group PLC	2,240,963	$157.2M
CWM, LLC	497	$34.9K